CFTR and cystic fibrosis: This work highlights the potential of silibinins and curcumin natural derivatives as therapeutic medicines for cystic fibrosis (CF) associated with mutant CFTR proteins by thorough molecular docking, molecular dynamics simulations, and ADME studies.